Well done.
Who would buy it? Why would anyone buy it? They've been around for 15 years and still have nothing to offer. Stem cell research was a good idea, but they couldn't get it working. It's a lost cause.
How about that jokoak. It sounds like some schizophrenic automation talking to itself.
Same here. I played GERN for a while, calls and puts, and it did pretty well. But then it plummeted to $1.09 and I decided to take my losses and get the hell out. I think this company will not exist by 2015. Maybe they will issue more shares few more times and that will last them a little longer, but after few more products they have will fail they will be history.
I don't wish them harm. Just have no confidence in their product and their management.
I don't think there is anything to sell here. I could be wrong about it, of course, but I have a feeling that Geron will burn through the rest of their cast and then won't be able to get any more public financing.
Thank you for quoting this. Now, can we get back to a real world and stop deluding ourselves that this is a high yield dividend stock?
0.87 annualized is assuming that it will continue paying .22 in each quarter. If you look back at div history you will see that it paid .22 in Feb 2013 and .16 in Feb 2012, but all other quarters were 6 cents each. You add it up and you get yourself a roughly 2% annual dividend yield. Not stellar at all.